European Investment Bank

Enpal GmbH is a Berlin-based company founded in 2017 that specializes in providing comprehensive renewable energy solutions, primarily through the installation and operation of solar panels for residential electricity generation. The company offers a range of products, including solar panels, batteries, wallboxes, heat pumps, and energy management systems, catering to customers in Germany and Italy. Enpal initially adopted a sales-based model but successfully transitioned to a lease model that requires no upfront payment and includes installation, insurance, and maintenance services. This approach has resulted in significant growth, with over 60,000 solar PV systems installed and revenues exceeding 400 million euros as of 2022. Enpal employs more than 1,000 team members, including over 200 local installer teams, and has opened several satellite offices to enhance customer service across its markets. The company has received numerous awards for its contributions to sustainability and customer service, positioning itself as a leader in the solar PV installation sector in Germany.

GEWOBA Aktiengesellschaft Wohnen und Bauen is a prominent real estate company based in Bremen, Germany, founded in 1924. The company specializes in residential real estate management, acquisition, construction, urban development, leasing, and brokerage services. In addition to its real estate operations, GEWOBA also oversees the Gewoba Foundation, established in 1999, which focuses on providing commercial and residential rental properties, along with property management and development services. The foundation's assets are managed by a dedicated board of directors, ensuring effective governance and operational oversight.

Vay is a Berlin-based deep technology company that is on track to launch the first driverless, safety-certified, commercial fleet on European public streets. The company aims to revolutionize urban transportation by enabling remote-controlled cars, offering a safer, more efficient solution for ride-hailing and vehicle-sharing services. Vay’s unique approach blends the advantages of self-driving technology with human supervision to ensure safety and adaptability in complex driving environments. Their goal is to reduce urban congestion, cut emissions, and make mobility more sustainable while providing a seamless transportation experience for users.

NVision Imaging Technologies GmbH, founded in 2015 and based in Ulm, Germany, specializes in the development and commercialization of innovative imaging and sensing applications grounded in quantum physics. The company has created a platform that polarizes natural metabolites, enabling their use as agents for imaging tumor metabolism through magnetic resonance imaging (MRI). This technology transforms standard magnetic resonance spectrometers into tools capable of assessing human metabolism, thereby enhancing the precision of cancer diagnostics and facilitating real-time monitoring of patient responses to therapy. By leveraging advances in quantum physics, NVision aims to make significant strides in the medical imaging and diagnostics sector.

Deutsche Glasfaser Holding GmbH, founded in 2012 and based in Borken, Germany, specializes in the planning, construction, and operation of fiber optic networks, particularly targeting rural and suburban areas. As a significant player in the broadband telecommunications sector, the company aims to facilitate nationwide fiber optic expansion, contributing to Germany's digital advancement. Deutsche Glasfaser focuses on delivering fast and cost-effective fiber-to-the-home (FTTH) connections in collaboration with municipalities, positioning itself as a leader in innovative planning and construction processes. With substantial backing from experienced investors, the company has established a strong financial foundation, making it one of the most robust providers in the German market.

Protembis GmbH, founded in 2017 and based in Aachen, Germany, specializes in the manufacture of surgical equipment aimed at enhancing the safety of transcatheter aortic valve replacement (TAVR) procedures. The company has developed the ProtEmbo System, an intra-aortic filter device designed to mitigate the risk of cerebrovascular events during TAVR by deflecting embolic material away from the cerebral circulation. This innovation addresses a significant complication associated with TAVR, which has become a preferred treatment for patients with valvular heart disease, particularly as the procedure is increasingly performed on younger and lower-risk individuals. By minimizing the risk of brain injury, Protembis aims to improve patient outcomes and reduce healthcare costs related to surgical complications.

Evonik Industries AG, headquartered in Germany, is a global specialty chemicals company. It operates in four major segments: specialty additives, smart materials, nutrition and care, and performance materials. Evonik produces and markets chemicals used in diverse industries, from automotive to pharmaceuticals, offering innovative solutions in areas such as animal nutrition, additives, smart materials, health care, and high-performance polymers. The company is a market leader in approximately 80% of its businesses and has a significant presence in Europe, North America, and Asia. Evonik Venture Capital, its corporate venture arm, invests in startups and venture capital funds with innovative technologies and high growth potential, focusing on areas such as resource efficiency, specialty additives, health & care, and nutrition.

VoltStorage GmbH, based in Olching, Germany, specializes in developing and producing power storage devices that utilize eco-friendly redox flow technology. The company's flagship product, VoltStorage, is a vanadium redox flow battery system designed to store excess electricity generated by solar panels during the day for use at night. This innovative approach enables homeowners to access renewable energy around the clock, promoting sustainability and environmental responsibility. In addition to its products, VoltStorage offers installation and technical support services, ensuring customers can effectively integrate these systems into their homes. The company aims to make renewable energy more accessible and contribute to a cleaner, fairer world for future generations.

Wingcopter GmbH, founded in 2014 and based in Darmstadt, Germany, specializes in the development and manufacture of advanced delivery drones for various applications, including medical supply chains and last-mile logistics. The company produces eVTOL, fixed-wing unmanned aircraft systems designed to efficiently deliver medicines, vaccines, blood, lab samples, parcels, and food to remote locations, as well as conduct inspections of public infrastructure. Its flagship model, the Wingcopter 198, features a patented tilt-rotor mechanism that allows for vertical takeoff and landing while maintaining the efficiency and range of a fixed-wing aircraft, even under challenging weather conditions. With a dedicated team of 120 professionals, Wingcopter aims to enhance and save lives through both commercial and humanitarian efforts, earning recognition as a Technology Pioneer by the World Economic Forum in 2020.

Smart Reporting GmbH is a Munich-based company that specializes in providing a digital health solution for structured medical reporting, particularly in the fields of radiology and pathology. Established in 2014, the company offers an online platform that enables radiologists to generate high-quality medical reports through intelligent software that adheres to guideline-compliant criteria. The platform facilitates the creation of report templates, automatic text suggestions, and integration with hospital systems, thereby enhancing the efficiency and quality of medical reporting. Additionally, Smart Reporting provides tools for hospitals and practices to implement reporting standards, optimize templates, and ensure consistent report appearance across various physicians. The company also supports medical registries and clinical studies with solutions for structured reporting, data collection, and multilingual capabilities, all aimed at improving communication and quality assurance in medical documentation.

SiPearl is a French semiconductor company established in 2019, headquartered in Maisons-Laffitte, Île-de-France, with research and development centers located in France, Germany, and Spain. The company specializes in the design of high-performance, low-power microprocessors intended for exascale supercomputers, aligning its product development with the European Union’s technological goals. Its first microprocessor range, Rhea, is set for commercialization in early 2024 and is based on the Arm Neoverse V1 architecture. SiPearl is committed to manufacturing Rhea using advanced processes from TSMC, ensuring state-of-the-art performance. The microprocessors are aimed at a variety of applications, including computing, artificial intelligence, medical research, climate change mitigation, and energy management, serving scientific researchers and major players in the IT, electronics, and automotive sectors.

numares AG is a German company specializing in the development and marketing of software-based test systems for clinical diagnostics and life science research. Founded in 2004 and based in Regensburg, the company utilizes nuclear magnetic resonance (NMR) spectroscopy and machine learning to analyze metabolomic networks. Its AXINON in vitro diagnostic system produces numeric spectra that provide critical information regarding patients' disease statuses, particularly in the fields of cardiovascular diseases, nephrology, oncology, and neurology. By employing magnetic group signaling (MGS) technology, numares AG offers a reliable, efficient, and cost-effective solution for NMR-based diagnostics, positioning itself as a leader in commercial NMR analytics in Europe while providing expert support to its customers.

SpinDiag GmbH is a medical technology company based in Freiburg, Germany, focused on developing automated point-of-care systems for the rapid and reliable detection of infectious diseases. Founded in 2016, the company has created a centrifugal-microfluidic test system that allows healthcare providers to screen for the 25 most common antibiotic resistances directly from patient samples upon hospital admission. This innovative system helps prevent the spread of drug-resistant bacteria by enabling the immediate isolation of infected patients. SpinDiag's first product is an automated SARS-CoV-2 test that provides laboratory-grade PCR results directly from standard patient swab samples, streamlining the workflow for nurses and integrating seamlessly into clinical practice. The fully automated system eliminates the need for manual pipetting, thereby minimizing the risk of infection and enhancing the efficiency of pathogen detection in hospital settings.

Aquila Capital is a private investment firm based in Hamburg, Germany, founded in 2001. It specializes in providing institutional investors, pension funds, foundations, and individuals with alternative investment solutions across real assets, financial markets, and private equity. The firm employs a multi-disciplinary investment approach, leveraging a team of dedicated specialists to manage a diverse range of investments, including hedge funds, private equity fund of funds, real estate, and infrastructure projects. Aquila Capital emphasizes strong operational frameworks and corporate governance to enhance its investment management capabilities. The firm operates additional offices in Frankfurt, Munich, and Vienna, and aims to identify and manage attractive investment opportunities for its clients through a solution-oriented approach that encompasses strategy development, implementation, and asset management.

Blickfeld GmbH, established in 2017 and based in Munich, Germany, specializes in the production of LiDAR sensors and associated software. These sensors, based on patented silicon MEMS mirrors and commercial off-the-shelf components, measure direct distance information in 3D, enabling autonomous vehicles to perceive and analyze their surroundings. The company's object detection and mapping software processes data from these sensors, facilitating applications in city planning, connected mobility, real-time mapping, and usage pattern analysis. Blickfeld caters to the automotive, transportation, industrial, and robotics sectors, offering low-cost LiDAR systems to support the mass market's transition towards autonomous mobility and IoT applications.

InstaFreight GmbH is a Berlin-based company that specializes in providing online freight forwarding services to B2B customers. Founded in 2016, InstaFreight aims to simplify the booking and processing of freight transport, making it fast and straightforward for businesses. The company focuses on delivering reliability, quality, and transparency, striving to become Europe's leading online freight forwarder. By offering innovative solutions and exceptional service, InstaFreight reduces the complexity of supply chains and enhances transparency for both customers and carriers.

TRUMPF, a German high-technology company, is a global leader in manufacturing sheet metal fabrication machinery, industrial lasers, and medical technologies. It offers a wide range of production solutions, including laser cutting, welding, and marking systems, as well as punching and additive production equipment. TRUMPF Venture, established in 2016, is the company's corporate venture capital arm, investing in early-stage startups that operate in areas complementary or adjacent to TRUMPF's core business, such as advanced photonics and smart factories. The venture capital arm seeks innovative technologies and business models, and provides funded startups with access to its extensive network, deep domain expertise, and support for scaling and market entry. TRUMPF, as an independent, family-owned company, focuses on long-term strategies and continuous innovation to drive digital connectivity in manufacturing.

DyeMansion GmbH, established in Munich, Germany in 2013, specializes in post-processing and coloring of 3D-printed laser sintered parts. The company offers high-volume finishing systems that transform raw, 3D-printed parts into high-value consumer and industrial products, such as eyewear, automotive components, and medical devices. DyeMansion works with major 3D printing systems like EOS, HP, and 3D Systems, enabling precision coloring and finish to exact specifications. With over 400 customers, including leading global manufacturers, DyeMansion has become the global leader in additive manufacturing finishing systems for 3D-printed polymer parts.

IDnow is a Munich-based company that specializes in identity verification technologies through its Identity-as-a-Service platform. Founded in 2014, IDnow employs advanced machine-learning techniques to offer real-time identity verification and electronic signing solutions, ensuring legal security and high data protection standards across Europe. Its services are tailored for business clients, including banks, telecommunications companies, and fintech firms, facilitating online customer identification and contract conclusion without the need for additional hardware. The platform allows users to verify their identities conveniently using smartphones, tablets, or webcams. IDnow's client roster features prominent organizations such as Commerzbank, UBS, Sixt neuwagen, Telefónica, and N26, highlighting its role as a key player in the identity verification sector.

Magazino GmbH, founded in 2014 and based in Munich, Germany, specializes in developing and manufacturing mobile robots for the storage and intralogistics sectors. The company offers advanced mobile pick-and-place robots designed for e-commerce warehouses, capable of identifying and localizing individual items using 2D and 3D cameras. These robots operate collaboratively as part of a swarm, utilizing the ACROS (Advanced Cooperative Robot Operating System) to receive and execute orders. Additionally, Magazino provides the App ARC (ACROS Robot Control) for monitoring robot fleets. Their technology aims to simplify and automate daily operations for mail-order companies, warehouses, production lines, and pharmacies, ultimately contributing to the evolution of robotics and the future of logistics.

CureVac is a clinical-stage biopharmaceutical company based in Germany, established in 2000, that specializes in developing vaccines and therapies utilizing messenger ribonucleic acid (mRNA). The company focuses on both prophylactic and therapeutic applications of mRNA, enabling the human body to produce proteins that combat various diseases. CureVac's innovative pipeline includes mRNA-based cancer immunotherapies, such as CV9104, which is in Phase IIb development for prostate cancer, as well as RNActive vaccines against infectious diseases and RNArt molecular therapies designed to stimulate the production of therapeutic proteins. Additionally, the company has collaborated with GSK to advance second-generation vaccines for seasonal influenza and COVID-19, alongside an avian influenza vaccine, while also exploring mRNA therapies for oncology and other conditions affecting the liver and eyes.

BioNTech is a Germany-based biotechnology company that specializes in developing innovative immunotherapies for cancer and other serious diseases, as well as vaccines for infectious diseases, including COVID-19. The company’s oncology pipeline includes a range of drug classes, such as mRNA-based drugs that encode antigens and neoantigens, cell therapies, bispecific antibodies, and antibody-drug conjugates. BioNTech has established partnerships with several major pharmaceutical companies, enhancing its research and development capabilities. Its COVID-19 vaccine, Comirnaty, represents its first commercialized product, demonstrating the company's commitment to addressing urgent health challenges through advanced therapeutic approaches.

ITM Isotopen Technologien München AG is a biotechnology and radiopharmaceutical company based in Garching, Germany, focusing on the development, manufacturing, and global supply of targeted diagnostic and therapeutic radiopharmaceuticals and radionuclides for cancer treatment. Established in 2004, ITM has built a robust global supply network and accomplished GMP manufacturing capabilities. The company offers a range of products, including EndolucinBeta, a radiopharmaceutical precursor for targeted radionuclide therapy, as well as radionuclides like 225Ac and 213Bi. Additionally, ITM develops automated systems for synthesizing radiolabeled biomolecules and provides GMP radiolabeling services. With a growing portfolio of innovative treatments and partnerships, ITM aims to enhance patient outcomes and quality of life in oncology, specifically addressing conditions such as neuroendocrine cancers and bone metastases while minimizing side effects.

Telefónica Deutschland is a prominent integrated telecommunications provider based in Munich, Germany, offering a wide range of mobile and fixed services for both private and business customers. The company manages approximately 49.6 million customer lines, with over 45 million in the mobile segment alone. Telefónica Deutschland's offerings include postpaid and prepaid mobile products, mobile data services utilizing GPRS, UMTS, and LTE technologies, as well as DSL fixed network telephony and high-speed internet services. Following its integration of E-Plus, the company is committed to digitalizing its business model while enhancing customer experience. With aspirations to become the preferred partner in the German mobile service market, Telefónica Deutschland aims to simplify and improve its customers' lives, providing them with mobile freedom in an increasingly digital world.

BioNTech is a Germany-based biotechnology company that specializes in developing innovative immunotherapies for cancer and other serious diseases, as well as vaccines for infectious diseases, including COVID-19. The company’s oncology pipeline includes a range of drug classes, such as mRNA-based drugs that encode antigens and neoantigens, cell therapies, bispecific antibodies, and antibody-drug conjugates. BioNTech has established partnerships with several major pharmaceutical companies, enhancing its research and development capabilities. Its COVID-19 vaccine, Comirnaty, represents its first commercialized product, demonstrating the company's commitment to addressing urgent health challenges through advanced therapeutic approaches.

FAZUA GmbH is a company that develops and manufactures innovative e-bike drive systems, aiming to enhance cycling mobility while preserving the natural feel of traditional biking. Founded in 2011 and headquartered in Munich, Germany, FAZUA's flagship product, the evation drive system, integrates an engine, gearbox, battery, and power electronics that can be easily removed and replaced with a cover. This design allows bike manufacturers to create sleek frames that discreetly house the drive system in the downtube. The company focuses on meeting the demands of sporty cyclists while providing a seamless transition between motorized and non-motorized riding experiences.

FlixBus, operated by FlixMobility, is a notable provider of intercity travel, focusing on affordable, convenient, and environmentally-friendly transportation solutions. Since its inception in 2013, the company has established Europe's largest long-distance bus network and introduced green long-distance trains in 2018, alongside a pilot for all-electric buses in Germany and France. The platform offers travelers a sustainable alternative to private transportation, featuring amenities such as free WiFi, flexible online booking, and innovative ticketing systems. FlixBus also expanded its services to the United States in 2018, bringing its unique travel model to a broader audience. By collaborating with regional bus partners and private train companies, FlixMobility combines technological innovation with traditional transportation expertise, positioning itself as a leader in the evolving mobility landscape. As a result, FlixBus has transformed the travel experience for over 100 million people across Europe and the United States while contributing to job creation in the mobility sector.

Curetis AG, founded in 2015 and based in Holzgerlingen, Germany, develops molecular diagnostics solutions aimed at detecting infectious diseases, pathogens, and antibiotic resistance markers. The company specializes in multiparameter testing, enabling the simultaneous analysis of various analytes in a single run. Its primary focus is on providing comprehensive panels for detecting severe bacterial infections, offering rapid diagnostic solutions that help physicians obtain early and actionable insights in managing infectious diseases and antimicrobial resistance. Curetis operates as a subsidiary of OpGen, Inc. and is positioned to expand its diagnostic capabilities into other clinical applications beyond infectious diseases in the future.

tado° GmbH is a technology company based in Munich, Germany, with an additional office in London, United Kingdom. Founded in 2010, it specializes in developing and marketing innovative home climate control systems that enhance the efficiency of heating and cooling in residential and small business environments. The company's products integrate a hardware-software combination that leverages real-time data on resident behavior, weather forecasts, and building characteristics to optimize climate management. tado° sells its solutions through both retail outlets and online platforms, effectively bringing Internet of Things technology to the cleantech market.

Indivumed was founded in Hamburg, Germany in 2002 with one main driver – the individualization of cancer therapy through the generation, characterization, and analysis of biologic samples from human cancer patients. Since then, the company has expanded globally, with a subsidiary in the USA, partnerships with leading cancer clinics in Europe, the US and Asia and more than 50 oncology practices located in Germany, and, finally, more than 100 biopharma industry partners – and a global reputation for product and service quality.

Arzneimittelwerk Warngau develops and markets drug delivery systems. Its portfolio includes active ingredient/biodegradable implants and transdermal systems in the areas of oncology, pain therapy, and neurology. It focuses on transdermal passive and microchip controlled patches, as well as subcutaneous biodegradable implants. Wilfried Fischer founded Arzneimittelwerk Warngau in 2008. It has its headquarters in Warngau in Germany.

medneo GmbH is a Berlin-based company that specializes in diagnostic imaging services, focusing on "radiology as a service." Rather than selling imaging equipment, medneo provides pay-per-use solutions for diagnostic image acquisition and reporting to radiologists, medical centers, and hospitals. Its innovative approach enhances operational efficiency, improves the utilization of imaging equipment, and delivers high-quality medical images and services at lower costs. This model not only streamlines the imaging process for healthcare providers but also improves patient access to radiology services, significantly reducing waiting times. Through its network of diagnostic centers and teleradiology sites, medneo aims to support healthcare professionals and institutions with comprehensive imaging solutions tailored to their needs.